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Obesity and diabetes represent a significant healthcare concern. In contrast to genome-wide association
studies that, some exceptions notwithstanding, have offered modest clues about pathomechanism, the
dissection of rare disorders in which obesity represents a core feature have highlighted key molecules and
structures critical to energy regulation. Here we focus on the primary cilium, an organelle whose roles in
energy homeostasis have been underscored by the high incidence of obesity and type II diabetes in patients
and mouse mutants with compromised ciliary function. We discuss recent evidence linking ciliary
dysfunction to metabolic defects and we explore the contribution of neuronal and nonneuronal cilia to these
phenotypes.Introduction
Obesity and diabetes are public health concerns that affect up to
15%of theworldpopulation (Chenetal., 2012). Theobservedhigh
heritability of these disorders (BMI heritability between 40 and
70%; Elks et al., 2012) has suggested that genetic approaches
may represent an opportunity to understand pathomechanism
and to develop better therapeutic paradigms. Driven by a com-
mon disease/common allele hypothesis, single-nucleotide poly-
morphisms (SNPs) in over 100 loci (Vattikuti et al., 2012), a variety
of endophenotypes such as waist-to-hip circumference (Vattikuti
et al., 2012), or discrete lipid traits (Wang et al., 2009) have been
associated with BMI. However, despite these exciting advances,
not only has each locus been found to contributemodestly to BMI
(Gusev et al., 2013), but the persisting dearth of causal genes,
alleles, and direction of effect have frustrated the elucidation of
molecular mechanisms and targetable pathways.
Although the field is optimistic that the accrual of genomic data
from increasingly expanding cohorts will improve common
allele-driven studies, an alternative approach, based on a rare
disease/rare allele hypothesis, has focused on rare, familial, typi-
cally penetrant, genetic disorders whose phenotypes include
obesity and diabetes. Such studies have made significant prog-
ress in extending our understanding of energy regulation derived
from the study of model organisms or have potentiated the iden-
tification of new key molecules altogether. One exemplar is mel-
anocortin and its receptors, mutations in some of which cause
familial morbid obesity (Vaisse et al., 1998; Yeo et al., 1998);
the genetic study of human populations coupled with functional
analysis of MC4R signaling revealed a contribution of this mole-
cule (and pathway) in more common forms of obesity as well
(Loos et al., 2008). Similarly, loss-of-function mutations in leptin
and its receptor have been correlated with perpetual starvation
in mice and profound obesity and type II diabetes consistent
with morbid obesity in humans (Chen et al., 1996; Zhang et al.,
1994). The concurrent identification of human mutations in
the ligand-receptor complex (Cle´ment et al., 1998; Montague
et al., 1997) has catalyzed a new wave of biochemical and
pharmacological efforts to characterize molecular targets and
signaling pathways relevant to the treatment of obesity.Here we will focus on the primary cilium, a structure that has
garnered significant attention recently with regard to its roles in
energy homeostasis; this is largely because mutations in genes
that compromise ciliary structure and function, in either humans
or model organisms, cause monogenic or oligogenic forms of
obesity, type II diabetes, and a host of metabolic defects. We
provide a framework to evaluate the role of proteins that localize
to the primary cilium or are necessary for its function in interpret-
ing the extracellular environment and energy homeostasis in
the central nervous system (CNS) and other sites of metabolic
regulation.
A Brief Overview of Cilia and Ciliopathies
Once considered a vestigial organelle, the primary cilium serves
a critical role in regulating diverse signaling pathways during
vertebrate development and disease (Hildebrandt et al., 2011;
Oh and Katsanis, 2012). Emanating from the basal body of
most vertebrate cells, cilia are classified broadly based on the
arrangement of the microtubule network as motile (containing
nine microtubule doublets forming a ring around a central pair
of single microtubules; 9 + 2 array) or nonmotile (nine microtu-
bule doublets forming a ring without a central pair of microtu-
bules; 9 + 0 array), with some exceptions to this rule (Baldari
and Rosenbaum, 2010; Gerdes et al., 2009; Kramer-Zucker
et al., 2005; Nonaka et al., 1998; Reese, 1965). Protein synthesis
is not thought to occur in the cilium; proteins are transported
through a series of highly regulated processes that include the
translocation of proteins from the cytoplasm to the axoneme
through the transition zone (Czarnecki and Shah, 2012), followed
by transport across the axonemal microtubules, a process
termed intraflagellar transport (IFT) (Kozminski et al., 1993).
In the context of disease burden in humans, historical
emphasis had been placed on structural abnormalities of motile
cilia that give rise to defects in left-right axis determination,
hydrocephalus, respiratory defects, and infertility (reviewed in
Yoshiba and Hamada, 2014). However, the discovery of a hypo-
morphic mutation in Ift88 in the orpk cystic renal mouse model
(Pazour et al., 2000) highlighted the critical importance of primary
cilia in the kidney; the subsequent identification of mutations inCell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc. 21
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(BBS) showed that dysfunction in primary cilia can cause a
host of phenotypes across body organs and, for the first time,
suggested a direct link between cilia and energy homeostasis
(Ansley et al., 2003). Since then, more than 50 causal loci
have been associated with >15 human genetic disorders,
including nephronophthisis (NPHP), Joubert syndrome (JBTS),
BBS, Meckel-Gruber syndrome (MKS), Alstrom syndrome
(ALMS), Jeune asphyxiating thoracic dystrophy (JATD) (Valente
et al., 2014) and others (Davis and Katsanis, 2012). Such disor-
ders are now classified under an umbrella term of ciliopathies
(Badano et al., 2006) which, although individually rare, have a
combined frequency of as much as 1:1,000 live births (Zaghloul
and Katsanis, 2009).
As widely studied models of ciliopathies, both BBS and ALMS
share common overlapping features such as obesity, rod-
cone dystrophy, and infertility, and less penetrant phenotypes
including type II diabetes and insulin resistance (the latter mani-
festing early in life in ALMS patients but late, if ever, in BBS
patients; Feuillan et al., 2011). Point mutations and deletions in
20 published genes have been linked to BBS (Lindstrand et al.,
2014, and references within), while mutations in ALMS1 account
for ALMS (Marshall et al., 2011). Unlike IFT88, and other
axonemal proteins, loss-of-function mutations in ALMS1 and
most BBS genes do not lead to the complete structural loss of
the cilium in most cell types. Instead, they disrupt the function
of the organelle, most prominently by perturbing the homeosta-
sis of a number of paracrine signaling cascades (Oh and Katsa-
nis, 2012). In the context of energy metabolism, mutant mice for
Alms1 and almost all Bbs genes (Bbs3 mutant mice are neither
hyperphagic nor obese; Zhang et al., 2011) generated to date
recapitulate several clinical features seen in patients, albeit
with variable penetrance and expressivity (Oh and Katsanis,
2012). These include obesity in both Alms1 and Bbs mutant
mice and diabetes in Alms1mutant mice (Arsov et al., 2006; Col-
lin et al., 2005). In parallel, cilia have been found in orexigenic and
anorexigenic neurons in the hypothalamus, suggesting a direct
link between these sites and obesity. At the same time, cilia
have also been detected in a number of distal sites, including ad-
ipocytes and muscle progenitors, with concomitant defects in
adipocyte differentiation (Marion et al., 2009; Przybylski, 1971),
suggesting that ciliary defects in the CNS might not be the sole
driver of the observed metabolic pathologies.
Establishing a Role for the Cilium in the Hypothalamus
Located adjacent to the floor of the third ventricle in the hypothal-
amus, the arcuate nucleus controls a range of neuroendocrine
functions in the brain that include energy balance and the regula-
tion of food intake. The arcuate nucleus is comprised of two
distinct populations of ciliated neurons: the orexigenic class of
neurons promote food intake and coexpress both neuropeptide
Y (NpY) and Agouti-related peptide (AgRP) (Broberger et al.,
1998; Hahn et al., 1998); the anorexigenic neurons attenuate
food intake and coexpress pro-opiomelanocortin (POMC) and
cocaine- and amphetamine-regulated transcript (CART) neuro-
peptides (Elias et al., 1998). NpY and POMC neurons are respon-
sive to the adipocyte hormone leptin and the pancreatic hormone
insulin. Leptin binds to the leptin receptor (LepR) (Ebihara et al.,
1999; Elias et al., 1998; Huang et al., 1998) and inhibits NpY neu-22 Cell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc.rons while activating POMC neurons. Of the five known leptin
receptor isoforms, the signaling capabilities reside primarily
with LepR-b which, upon stimulation, results in the activation of
Akt and STAT3 (Friedman and Halaas, 1998; Vaisse et al.,
1996). The phosphorylation and activation of STAT3 have
opposing transcriptional effects on the pomc and agrp pro-
moters, leading to increased expression of POMC and the inhibi-
tion ofNpY (Ernst et al., 2009;Mesaros et al., 2008). As a common
molecular switch, STAT3 is also activated in response to other
satiety signals, such as insulin (Varela and Horvath, 2012).
The observation of cilia in hypothalamic neurons stimulated a
major effort to establish whether ciliary proteins regulate energy
homeostasis (Davenport et al., 2007). Global ablation of cilia is
not compatible with life; therefore, a first undertaking to query
a physiological role for the cilium was to delete IFT genes using
tamoxifen-inducible conditional Ift88 or Kif3a knockout mice.
Systemic ablation of Ift88 orKif3a in adult mice resulted in hyper-
phagia-induced obesity with increased leptin, glucose, and insu-
lin levels (Davenport et al., 2007). Pair-fed mutant Kif3a mice did
not develop obesity or show elevated fasting serum glucose and
insulin, suggesting that defective cilia may result in defective
feeding behaviors. To test whether neuronal cilia may be driving
disease phenotypes, both Kif3a and Ift88-floxed mouse lines
were bred to a Synapsin I-Cre driver to remove cilia exclusively
in neurons (Davenport et al., 2007). Similar to the tamoxifen-
inducible lines, hyperphagia-induced obesity was observed,
suggesting that neuronal cilia can participate directly in the regu-
lation of energy homeostasis. Further studies characterizing a
POMC-dependent deletion of Kif3a led to the observation of sig-
nificant weight gain in adult mice (Figure 1), reinforcing the
potential role of hypothalamic neuronal cilia in the observed phe-
notypes (Davenport et al., 2007). Taken together, these studies
do support a role of ciliary proteins in obesity. However, given
that both KIF3A and IFT88 have roles in cytoplasmic microtu-
bule-based transport (Finetti et al., 2009; Muresan et al., 1999),
direct proof that defects of the ciliary structure per se are neces-
sary and sufficient to explained the observed pathologies is
lacking. Nonetheless, additional indirect evidence has become
available; a variety of proteins involved in ciliary and basal
body function (but not cytoplasmic transport) have now been
associated with syndromic obesity in humans, while a number
of key signaling components known to regulate energy meta-
bolism have also been observed in the neuronal primary cilium.
Somatostatin receptor 3 (SSTR3) and melanin-concentrating
hormone receptor 1 (MHCR1) contain a ciliary targeting signal
that promotes localization to the neuronal cilium in the hypothal-
amus (Berbari et al., 2008). Binding of the somatostatin and
melanin-concentrating hormone G protein-coupled receptors
(GPCRs) inhibits the release of glucagon and insulin in postpran-
dial states. Importantly, SSTR3- and MHCR1-expressing neu-
rons are also leptin responsive (Stepanyan et al., 2003). Genetic
ablation of Bbs2 and Bbs4 in the mouse was shown to result in
the loss of Sstr3 and Mhcr1 localization to primary cilia (Berbari
et al., 2008). Given the observation of hyperphagic-induced
obesity in Bbs2/ and Bbs4/ mice, perturbation of Sstr3
and Mchr1 ciliary targeting was thus correlated with the regula-
tion of satiety signals (Berbari et al., 2008). The role of Sstr3 in the
brain has also been studied in foz/foz mice, where truncated
Alms1 protein fails to localize to the cilium in hypothalamic
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Figure 1. Hypothalamic Neuronal Cilia Regulate Energy Metabolism
Neuronal cilia emanating from POMC-expressing neurons regulate obesity phenotypes in the ciliopathies. Under normal conditions, neuronal cilia and the
BBSome complex may serve to modulate signaling from the leptin receptor and/or other receptor complexes. Upon perturbation of the cilium, mistrafficking of
receptor complexes leads to the inactivation of STAT3 and to dysfunctional cellular signaling.
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Reviewneurons. Unlike Bbs mouse mutants, expression of truncated
Alms1 leads to fewer ciliated neurons in the hypothalamus (Hey-
det et al., 2013). Surprisingly, no significant difference in Sstr3
andMhcr1 ciliary localization was observed in foz/fozmice (Hey-
det et al., 2013), arguing that perturbation of ciliary targeting of
GPCRs to the cilium is not always necessary to give rise to
obesity.
Leptin plays a central role in regulating energy intake through
the activation of anorexigenic pathways in the hypothalamus
(Figure 2); however, it is unclear whether leptin resistance is a pri-
mary or secondary cause of obesity. Leptin resistance is definedas the inability of elevated leptin levels to curb adiposity in com-
mon obesity. Such phenomena have been attributed to obesity
phenotypes observed in Bbs2/, Bbs4/, and Bbs6/mutant
mice, all of which have been reported to be hyperleptinemic
(Rahmouni et al., 2008). Additionally, attenuated POMC tran-
script levels in the hypothalamus of these mutants suggested
that circulating leptin cannot stimulate transcriptional activation
of POMC expression (Rahmouni et al., 2008). Defective LepR-b
trafficking in Bbs mutant mice further bolstered the hypothesis
that leptin resistance might contribute to obesity in BBS. The
mislocalization of LepR-b to large intracellular vesicles uponCell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc. 23
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Figure 2. Evaluation of the Role of Cilia during Energy Homeostasis
Several covariates drive obesity phenotypes in the ciliopathies. In the adipose tissue, depletion of BBS proteins leads to the loss of cilia from preadipocytes; the
failure to respond to environmental cues through the primary cilium results in the perturbation of adipogenesis. In the pancreas, depletion of IFT proteins results in
the transformation of centroacinar cells to ductal-like cells. Insulin, leptin, and potentially other, uncharacterized factors regulate neurons in the hypothalamus,
which are also sensitive to the loss of cilia. This figure was, in part, prepared using Servier Medical Art (http://www.servier.com/Powerpoint-image-bank).
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LepR-b with Bbs1 argue that the leptin receptor localizes
possibly to the primary cilia in a manner dependent on the secre-
tory pathway and the BBSome (Seo et al., 2009).
Does Leptin Resistance Contribute to Obesity in
Ciliopathies?
Although data from conditional Ift mouse mutants outline a
requirement of primary cilia in the hypothalamus for energy
homeostasis, the function of neuronal cilia in regulating satiety
signals through LepR-b remains unanswered. Recent studies
utilizing tamoxifen-induced ablation of Ift88 (Ift88D/D) in adult
mice (8 weeks) examined the role(s) of cilia and leptin signaling
in obesity (Berbari et al., 2013). Following tamoxifen administra-
tion at 8 weeks, a lean phase persisted for about 3 weeks,
where the body weight of mutant mice did not differ significantly
from that of littermates. While ad libitum feeding resulted in
obesity at 3 months of age, caloric restriction of Ift88D/D mice
led to a recovery in body weight to wild-type levels from the24 Cell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc.obese phase at 5 months of age. Mice were categorized into
three chronological phases—lean, obese, and lean—based on
their body weight post tamoxifen administration. Ift88D/D mu-
tants exhibited elevated serum leptin with respect to body fat
and peaked during the obese phase. A striking feature of these
analyses was the return of serum leptin levels to wild-type levels
in the late lean phase (5 months). Furthermore, activation of p-
STAT3 in the arcuate nucleus upon leptin administration during
the initial lean phase in Ift88D/D mice suggested that loss of cilia
does not perturb leptin signaling in the hypothalamus. Similarly,
leptin administration in preobese Bbs4/ mice results in
anorexia (Berbari et al., 2013). These observations differ from
earlier studies carried out in Bbs2/, Bbs4/, and Bbs6/
mice, in which serum leptin levels at 5–6 weeks of age was
significantly higher in all three Bbs null mice (Rahmouni et al.,
2008). Moreover, a 4 day regimen of leptin administration failed
to reduce the body weight in Bbs null mice (Rahmouni et al.,
2008), whereas a similar experiment resulted in reduced food
intake in preobese Bbs4/ and Ift88D/D mice (Berbari et al.,
Cell Metabolism
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previous studies were performed on mice from different back-
ground strains; such variables have been reported exhaustively
to sensitize experimental parameters affecting preobese and
obese phases (Ewart-Toland et al., 1999) and warrant further
investigation. More recently, an alternate hypothesis has been
proposed that the mislocalization of other GPCRs to the cilium
may be responsible for hyperphagia-induced obesity in BBS
(Loktev and Jackson, 2013). A screen for novel ciliary GPCRs
led to the identification of NpY receptor NPY2R as a candidate
anorexigenic receptor defective in hypothalamic signaling in
BBS and tubby (a ciliary protein required for the trafficking of
GPCRs to neuronal cilia; mouse mutants show retinal degener-
ation and obesity phenotypes; Mukhopadhyay et al., 2010;
Sun et al., 2012) mutant mice. Importantly, mutant BBS mice
were nonresponsive to treatment with PYY3-36, an endoge-
nous ligand to NPY2R, suggesting that ciliary targeting of addi-
tional GPCRs (Figure 1) may either drive or modulate the obesity
phenotypes observed in ciliopathies (Loktev and Jackson,
2013).
To rationalize the role of the cilium and leptin in energy meta-
bolism, the following observations should be considered: (1)
obesity resulting from systemic and tissue-specific ablation of
Kif3a and Tg737 in POMC neurons, (2) increased weight gain
in Bbs null mice coupled with reduced p-STAT3 levels in the hy-
pothalamus, (3) mislocalization of LepR from cilia of ARPE cells
upon ablation of BBS1 and BBS2, and (4) a biochemical interac-
tion between LepR-b and basal body proteins such as BBS1 and
RPGRIP1L (Stratigopoulos et al., 2014). However, the data that
indicate that ciliary defects might be secondary to the onset
of metabolic dysfunction are (1) a positive leptin response in
Ift88D/D mice during the initial and late lean phase, (2) increased
p-STAT3 signal in the hypothalamus in response to leptin, (3)
that additional GPCRs modulate obesity phenotypes in BBS,
(4) localization of LepR throughout the plasma membrane in
ARPE cells. These observations suggest that, irrespective of
whether leptin signaling is driven by ciliary mechanisms, loss
of cilia in POMC neurons leads to obesity in mice. If activation
of p-STAT3 is deterministic for leptin signaling, then it can be
postulated that primary cilia are not required for leptin signaling
in the arcuate nucleus, due to a positive leptin response in
Ift88D/D mice. Taken together, the signal output from leptin-
dependent activation appears to be modulated by ciliary and
nonciliary mechanisms which in toto appear to regulate energy
homeostasis.
Cilia Biology in Adipocytes and the Pancreas
Despite the functional relevance of cilia to hypothalamic neu-
rons, a defective CNS is one of several covariates that can drive
obesity phenotypes in ciliopathies (Figure 2). The human adipose
tissue contains adipocytes that are insulin sensitive and regulate
lipid storage and hormone secretion. Adipocytes are derivatives
of the mesenchymal lineage of stem cells that differentiate as
preadipocytes before maturation to terminal adipocytes (Pit-
tenger et al., 1999). Mature adipocytes are unique vertebrate
cells, as they are not thought to be ciliated; however, a transient
primary cilium has been described during the differentiation of
preadipocytes (Marion et al., 2009). To evaluate the relevance
of the transient cilium, transcriptomic analyses were conductedto ask whether ciliary proteins are expressed during adipogene-
sis. Expression analyses revealed a significant upregulation of
BBS1–BBS4, and BBS6–BBS12 expression during the differen-
tiation of preadipocytes (Forti et al., 2007; Marion et al., 2009).
Next, BBS10 and BBS12 were suppressed in confluent primary
preadipocytes and cultured in preadipocyte differentiation me-
dium containing D-Glucose and insulin. Two days after such
treatment, proadipogenic peroxisome proliferator-activated re-
ceptor g (PPARg) was detected in BBS10 and BBS12-depleted
preadipocytes, suggesting that a functional cilium/basal body
can negatively regulate adipogenesis. These results are in
contrast with studies showing a downregulation of PPARg sup-
pression of Alms1 and IFT proteins in transformed 3T3-L1mouse
preadipocytes (Huang-Doran and Semple, 2010). However,
given that human preadipocytes can proceed to terminal differ-
entiation without postconfluence mitosis, differences in PPARg
responsiveness may be attributed to cell line-specific variables.
In addition, ciliopathy proteins localize to subcellular structures
other than the cilium and basal body (Collin et al., 2012; Delaval
et al., 2011), raising the possibility that these unique localiza-
tion patterns may account for some of the discrepancies
between studies on human preadipocytes and 3T3-L1 mouse
preadipocytes.
The exocrine (enzyme secretion) and the endocrine glands
(hormone secretion) constitute the pancreas. The islets of Lang-
erhans are patches of endocrine tissue that contain a, b, g, d,
and ε cells that secrete glucagon, insulin, pancreatic polypep-
tide, somatostatin, and ghrelin, respectively (Collombat et al.,
2010). Insulin is one of the central regulators of energy homeo-
stasis and is secreted in response to glucose and leptin
(Collombat et al., 2010). Pancreatic defects are penetrant phe-
notypes in ciliopathies; they manifest mostly as pancreatic cysts
originating from ducts cells in ADPKD, ARPKD, von Hippel-
Lindau disease, and other ciliary disorders (Table 1). Both
severe exocrine defects and milder endocrine defects, such
as reduced glucose tolerance and lower fasting blood glucose
levels, have been reported in the hypomorphic Tg737orpkmutant
mice (Zhang et al., 2005). In addition, acinar-to-ductal meta-
plasia, fibrosis, and lipomatosis were observed in pancreas-
specific Kif3a-deleted mice (Cano et al., 2006). To evaluate
whether primary cilia are necessary for the development of
pancreatic islets, Kif3a was ablated at E10 or at 4 weeks of
age. Normal development of the pancreas was observed, sug-
gesting that the regulation of hormonal levels and islet formation
are mutually exclusive (Cano et al., 2006). Although most IFT
models of ciliopathies studied to date lead to pancreatic ductal
dilations and cyst formation, no changes in insulin secretion
have been observed. However, insulin secretion and the ciliary
apparatus were associated upon examination of mice lacking
Regulatory factor X, 3 (RFX3) (Ait-Lounis et al., 2007) and Gli-
similar proteins 3 (Glis3) (Kang et al., 2009). Both RFX3 and
Glis3 are transcription factors necessary for normal ciliary func-
tion; deletion of either gene results in pancreatic ductal defects
in mice and decreased insulin secretion with impaired glucose
tolerance. Given that structural deficits in the cilium may not
be linked causally to insulin secretion, the previous findings
may be explained due to ciliary proteins functioning both at
the cilium and other organelles, which together influence insulin
secretion and energy regulation.Cell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc. 25
Table 1. Pancreatic Defects Are Penetrant Phenotypes in the Ciliopathies
Gene Species Phenotype Reference
Pkd1 truncation Mouse Pancreatic cysts Lu et al., 1997
Pkhd1 (PCK) Rat Pancreatic duct dilation Lager et al., 2001
Inv Mouse Pancreatic cysts Morgan et al., 1998
Ift88 (Tg737) Mouse Pancreatic duct dilation or elevated insulin upon
POMC-specific deletion
Cano et al., 2004; Davenport
et al., 2007
Kif3A (pancreas specific) Mouse Cyst formation, aberrant ductal morphology, and
extensive fibrosis
Cano et al., 2006
Hnf6 Mouse PKD and pancreatic cysts Pierreux et al., 2006
Alms1 (Fat Aussie) Mouse Islet cysts Arsov et al., 2006
Rfx3 Mouse Altered pancreatic endocrine cell differentiation Ait-Lounis et al., 2007
Pkhd1 (del2/del2) Mouse Pancreatic cysts and some pancreatic enlargement Woollard et al., 2007
Kif3A (POMC-Cre) Mouse Elevated insulin Davenport et al., 2007
Pkhd1 (del4/del4) Mouse Pancreatic cysts Gallagher et al., 2008
NPHP3 Human Pancreatic cysts Bergmann et al., 2008
Pkhd1 Rat Pancreatic duct dilation Yi et al., 2012
VHL Human Pancreatic cysts and pancreatic neuroendocrine tumors van Asselt et al., 2013
NEK8/NPHP9 Human Enlarged pancreas Frank et al., 2013
Analysis of mouse loss-of-function mutant models of ciliary genes reveals aberrations in pancreatic function.
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Primary cilia are signaling hubs for a host of paracrine signaling
pathways. While over 15 distinct signaling pathways have been
associated to the cilium, the relevance of Wnt and Sonic Hedge-
hog (Shh) signaling to the ciliary apparatus has been most inten-
sively studied over the last decade (Oh and Katsanis, 2013). Wnt
ligands comprise a class of secreted glycoproteins that regulate
conserved functions ranging from the development of the body
axis to the regulation of cell polarity (Willert and Nusse, 2012).
Activation of the canonical pathway results in the stabilization
of b-catenin through disruption of the destruction complex
comprising of axin, casein kinase, GSK3b, PP2A, and adenoma-
tous polyposis coli, while the noncanonical pathway influences
processes such as calcium levels and actin modification. Cilia
are thought to control the balance between canonical and non-
canonical Wnt signaling, and components of the Wnt signaling
machinery (b-catenin, adenomatous polyposis coli, and frizzled
receptors) localize to the ciliary axoneme (Oh and Katsanis,
2012). Leptin activates Wnt signaling via GSK3b inhibition in at
least 70% of NpY neurons, suggesting that the catabolic action
of leptin is transduced through hypothalamic WNT signaling
(Benzler et al., 2013).
The process by which preadipocytes differentiate into
mature adipocytes is controlled by Wnt proteins; inhibition of
Wnt signaling promotes differentiation, and activation terminates
adipogenesis (Ross et al., 2000; Wright et al., 2007). In vivo sup-
port for thismodel was demonstratedwhenwild-type or Lepob/ob
mice expressing Wnt10b under the control of the adipose-spe-
cific FABP4 promoter showed a 50% reduction in total body
fat (Longo et al., 2004; Wright et al., 2007). As might be pre-
dicted, in reciprocal studies using mice lacking Wnt10b, an
increased adipogenic potential was observed, supporting the
notion that Wnt signaling controls adipogenesis (Vertino et al.,
2005). Adipogenesis is promoted through activation of the
CCAAT/enhancer binding proteins (C/EBPs) and peroxisome26 Cell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc.proliferator-activated receptors (PPARs) (Ross et al., 2000). To
explore a role for the basal body/cilium in adipogenesis,
BBS10 or BBS12 was suppressed in differentiating human pre-
adipocytes in culture; perturbation of the basal body resulted
in elevated levels of nuclear PPARg and active GSK3b (Marion
et al., 2009). In addition, adipocyte-derived dermal fibroblasts
from patients carrying mutant BBS10 or BBS12 also displayed
a significant increase in triglyceride content and higher secreted
leptin levels in culture medium, suggesting that enhanced adipo-
genesis is likely a direct consequence upon loss of basal body
proteins.
Similar to Wnt, Hedgehog (Hh) signaling is a conserved
pathway that is required for embryonic development and the
maintenance and regeneration of adult tissue. Upon binding of
the ligand, Smoothened (Smo), a seven-membrane-spanning re-
ceptor, is relieved from inhibition by Patched (Ptc) and processes
Gli proteins into an activator form (GliA) in the cilium. Gli activator
proteins translocate to the nucleus and transactivate down-
stream targets such as Axin2. Several components of the Hh
pathway (Smo, Ptc, and Gli proteins) have been localized to
the primary cilium in multiple cell types, including neurons and
adipocytes (reviewed in Oh and Katsanis, 2012). Similar to
Wnt, Hh signaling functions in an antiadipogenic manner
and activation of the pathway leads to a reduction in PPARg
expression in adipogenic cells. While total suppression of Wnt
signaling is necessary for differentiation of adipocytes, residual
Hh responsiveness can be detected in mature adipocytes, sug-
gesting that inhibition of Hh signaling is not a fate-determining
step during adipogenesis (Pospisilik et al., 2010). To query
whether the basal body/cilium is relevant to Hh signaling and
adipogenesis, suppression studies of BBS12 were performed
in cultured human adipocytes derived from human mesen-
chymal stem cells (Marion et al., 2012). Together with an increase
in nuclear PPARg during adipogenic differentiation, attenuation
of Gli2 and Gli3 expression was observed, indicating that
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antiadipogenic program. Cognizant that these results may be
due to cell-line-derived artifacts, Bbs12/ mice were gener-
ated; similar to in vitro studies, defects in insulin sensitivity
and glucose absorption were observed (Marion et al., 2012).
Together, these results suggest that ciliary mechanisms and
Hh signaling are relevant to energy regulation in adipose tissue
and contribute to obesity phenotypes observed in BBS. Of
note, a role for Hh signaling in the homeostasis of adult hypotha-
lamic neurons has not been elucidated.
As an antiadipogenic signal, canonical Hh signaling inhibits
adipogenesis in white adipose tissue by blocking the differentia-
tion of white adipocytes, but not brown fat andmuscle. However,
a recent noncanonical Hh signaling pathway has been charac-
terized to promote insulin-independent glucose uptake in brown
adipose tissue and muscle (Teperino et al., 2012). Through other
work demonstrating that Hh can acutely increase Ca2+ spike ac-
tivity in neurons (Belgacem and Borodinsky, 2011), Smo-depen-
dent activation of Ca2+ and AMP kinase (AMPK) was observed in
human and mouse myocytes, leading to glucose uptake and re-
programming to a glycolytic state. Given that both canonical and
noncanonical pathways are dependent on a functional cilium, Hh
signaling effectors may hold therapeutic value in combating
obesity and diabetes (Teperino et al., 2012).
Recently linked to the cilium is a degradative process known
as autophagy (Pampliega et al., 2013; Tang et al., 2013). Activa-
tion of autophagy occurs under conditions of nutrient depriva-
tion, as well as during development and differentiation (Jing
and Lim, 2012). In light of a positive correlation between ciliogen-
esis and serum deprivation, tandem affinity purification was
performed to identify potential ciliary interactors of LC3, a key
effector of autophagy. Among several known cargo-adaptor pro-
teins required for recruiting cargo to the autophagasome,
centriolar satellite proteins such as PCM1, CEP131, and OFD1
were found to associate with LC3. During serum deprivation,
OFD1 protein levels were reduced in wild-type cells, but not in
autophagy-deficient Atg5/ MEFs, suggesting that autophagy
initiates ciliogenesis through degradation of OFD1 (Tang et al.,
2013). Under normal nutrient conditions, OFD1 protein levels
are unaffected; however, ciliogenesis is not favored through
sequestration and degradation of IFT20 in autophagasomes
(Pampliega et al., 2013). While these data suggest that the
autophagy machinery localizes to the cilium and basal body,
colocalization studies under serum deprivation and compro-
mised IFT (Ift88/ cells) conditions verified that multiple
autophagy-related proteins associated with the ciliary axoneme
(ATG16L, AMBRA1, LC3, GABARAP, and VPS15) and basal
body (ATG16L, AMBRA1, LC3, GABARAP, VPS15, ATG14,
VPS34, ATG7, and ATG5) (Pampliega et al., 2013).
Although it is unclear whether OFD1 degradation occurs at the
hypothalamus and/or other sites of energy regulation, the role
of autophagy during food intake is well established. In the hypo-
thalamus, inhibition of the autophagasome in orexigenic and
anorexigenic neurons can regulate metabolism; mice lacking
Atg7 in POMC neurons have higher postweaning body weight,
increased adiposity, and glucose intolerance (Coupe´ et al.,
2012), while deletion of Atg7 in AgRP neurons results in signifi-
cantly reduced body weight and total fat mass (Kaushik et al.,
2011). In addition, mice lacking Atg7 in POMC neurons are notresponsive to leptin, and STAT3 activation is not observed
(Coupe´ et al., 2012), suggesting that hypothalamic autophagy
controls appetite and/or bodyweight. Similarly, adipose-specific
deletion of Atg7 yielded mutant mice with 20% of the mass of
white adipose tissue found in wild-type mice (Zhang et al.,
2009). Given the localization of ATG7 to the basal body and
the overlapping phenotypes between ciliary and autophagy
mutants, we predict that mechanisms regulating autophagy
and ciliogenesis will likely contribute to energy balance.
Alternate Mechanisms of Signal Acquisition
A consistent theme that has emerged upon analyzing ciliary mu-
tants is that disease phenotypes can be correlated with ciliary
length changes. Upon exposure to aqueous cigarette smoke
extract, autophagasome accumulation and autophagic activity
in the lungs are observed in conjunction with shortening of the
cilium (Lam et al., 2013). The severity of the cilia defect is a func-
tion of the concentration of cigarette smoke; higher cigarette
smoke doses yield cilia that are 50% shorter, while lower doses
result in cilia that are 20% shorter. Equivalently, significantly
shorter neuronal cilia can be observed in the hypothalamus of
diet-induced obese (DIO) mice and leptin/leptin-receptor-defi-
cient mice (Han et al., 2014). Changes in the ciliary length pheno-
types in DIO mice are prominent for several reasons: (1) the
phenotype is confined specifically to the ventromedial hypothal-
amus, with no changes in the CA3 region of the hippocampus;
and (2) infusion of leptin in the third cerebroventricle rescues
the short cilia phenotype. Given the changes in circulating leptin
levels upon a lean and high-fat, high-sucrose diet for 14 weeks
and that Bbs and Alms1 mutant mice develop leptin resistance
prior to becoming obese, can leptin directly promote changes
in ciliary length? Stimulation of either N1 hypothalamic neurons
or primary hypothalamic cells with leptin for 12 hr leads to an
50% increase in ciliary length (Han et al., 2014). In addition,
localization of a tagged leptin-receptor complex at the basal
body suggested that leptin signaling machinery is associated
with the cilium. Together the results argue that ciliary length in
the hypothalamus can report leptin signaling strength during
energy homeostasis.
Changes in ciliary length have also been appreciated in renal
medullary cells fromBbsmice and bbs7- or bbs9-depleted para-
mecia; however, shorter cilia have not been reported in the hypo-
thalamus of Bbs or Alms1mutant mice. These data suggest that
in addition to ciliary length and transport defects, other mecha-
nisms must also account for the control of neuroendocrine func-
tion. Taking advantage of conservation in BBSome components
in C. elegans and that disruption of bbs or ift proteins results in
structural ciliary defects and diminished sensory behavioral re-
sponses seen in mammalian BBS and IFTmutants, Lee and col-
leagues asked whether alternate hypotheses could be explored
in an organismwith 60 ciliated sensory neurons (Lee et al., 2011).
Like other species,C. elegans sense changes in the environment
and secrete neuroendocrine hormones, including insulin-like
peptides, in response to stress. Given the role of ciliated neurons
in the secretion of hormones, ciliary defects should perturb this
function. As predicted, multiple ift C. elegans mutant lines pre-
sented a dramatic reduction in insulin secretion. BBS proteins
are also utilized to facilitate IFT in neurons; therefore, it was sur-
prising to observe an increase in insulin secretion in mutant linesCell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc. 27
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pected that the failure in insulin secretion must be independent
of impaired IFT. Given the increase in insulin secretion and the
observation of elevated secretions of dense-core vesicles, the
BBSome complex may also regulate exocytosis. Further assays
showed that a Rab27/rabphillin/CAPS exocytosis machinery
functioned together with bbs proteins to promote vesicular
transport. Interestingly, the altered body size and feeding and
metabolic abnormalities in bbs mutants in C. elegans can be
corrected by inhibiting the release of dense-core vesicles, sug-
gesting that excessive neuroendocrine signaling activity may ac-
count for a fraction of BBS disease phenotypes (Lee et al., 2011).
Concluding Remarks
The combination of genetic discoveries in humans, tissue-spe-
cific transgenic mouse models, and biochemical studies in cells
and organisms has highlighted multiple roles of ciliary proteins in
energy regulation and metabolism. These studies reinforce the
role(s) of hypothalamic neurons and leptin signaling and also un-
derscore the potential contribution of adipocyte differentiation in
human disease phenotypes. These initial discoveries have now
formed the platform to ask the next sets of questions, which
are many. First, significant discrepancies remain to be resolved
from existing data. Different ciliopathy mouse models exhibit
obesogenic characteristics driven by apparently discrete com-
ponents of signaling processes that may or may not be modu-
lated by the cilium (the anatomical structure) or by hitherto
unknown functions of ciliary proteins elsewhere in the neuronal
soma. For example, cilia assembly in new neurons from the den-
tate gyrus occurs during a period that corresponds to glutama-
tergic synaptic activity (14–21 days after birth), highlighting the
possibility that (1) proteins that are required for cilia formation
are also required for synaptogenesis or (2) the cilium signals
directly to the synapse (Kumamoto et al., 2012). In addition,
the variable expressivity, severity, and temporal differences in
ciliopathy mouse models of obesity are not understood. It will
be important to determine whether differences between mouse
models are driven by discrete functions of ciliary proteins or
genetic background; answering this question offers a perhaps
unique opportunity to understand the variance of the phenotype
in humans and to uncover new pathways and processes. An
exemplar of variable expressivity and obesity can be highlighted
in the correlation of dose-dependent body weight difference in
humans and common variants in the first intron of the fat
mass- and obesity-associated gene (FTO) (Frayling et al.,
2007). SNPs associated with increased BMI are hypothesized
to control the expression of the ciliary gene, RPGRIP1L. Hetero-
zygous knockout mice for RPGRIP1L are hyperphagic and have
a higher body weight, demonstrating that the regulation of
adiposity can be embedded in the regulatory elements of genes
near FTO (Stratigopoulos et al., 2014). In addition to common
variants showing an effect on complex diseases, analysis of
large exome sequence-based approaches have revealed that
rare variants in BBS10 can also influence type 2 diabetes (T2D)
susceptibility (Lim et al., 2014). Taken together, both common
and rare variation in ciliopathy genes are likely to modulate
obesity and T2D phenotypes. Finally, it remains unclear why
obesity manifests in some but not all ciliopathies, even though
the protein products of themutated proteins colocalize with obe-28 Cell Metabolism 21, January 6, 2015 ª2015 Elsevier Inc.sogenic molecules. This observation is most striking given that
obesity is a core component of BBS and ALMS, a secondary
feature in JBTS and of no clinical note in NPHP or polycystic
kidney disease (PKD).
The model of obesity leading to leptin and insulin resistance in
BBS, as per recent studies, may not be the precursor to obesity
but a consequential body response with respect to increased
food intake. BBS proteins may function to simply localize
SSTR3, MCHR1, or other receptors to the cilium, thereby regu-
lating food intake and feeding behaviors which can lead to
obesity in BBS and ALMS. Although the role of BBS proteins
has been studied with respect to adipogenesis, their role in en-
ergy expenditure in terms of mobilizing stored lipids is not
known. Dietary deprivation of an essential amino acid, leucine,
has been shown to increase lipolysis in brown adipose tissue
by activating uncoupling protein (UCP-1) and results in higher
thermogenesis (Cheng et al., 2010), suggesting possible studies
addressing lipolysis in BBS mouse models. But is the obesity
in BBS a result of just stored fat which cannot be burnt? While
this question needs to be addressed, the hyperphagic Kif3a
knockout mouse model being corrected for its obesity by calorie
restriction is a promising study that requires translation to a
human ciliopathy such as BBS. The counterargument for this
hypothesis is whether loss of Kif3a can be considered equal to
loss of BBS. Nevertheless, this takes us back to the idea that
‘‘we are what we eat,’’ and regulating food intake to alleviate
morbid obesity in BBS subjects in early childhood would,
at least, reduce possible secondary effects such as leptin and
insulin resistance.
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